Table 2.
Author | Patients, No. | Age, y | Follow‐Up, y | CHD, HR (95% CI) | CVD, HR (95% CI) |
---|---|---|---|---|---|
Knoops4 | 2339 M+W | 70–90 | 10 | 0.27 (0.14–0.53) | 0.33 (0.22–0.47) |
Daviglus5 | 7302 W | 18–39 | 31 | 0.13 (0.04–0.45) | 0.20 (0.09–0.43) |
Chiuve6 | 4287 M | 40–75 | 16 | 0.13 (0.09–0.19) | – |
Odegaard7 | 44,056 M+W | 45–74 | 11 | 0.23 (0.14–0.37) | 0.24 (0.17–0.34) |
Eguchi8 | 43,010 M+W | 40–79 | 17 | M: 0.19 (0.07–0.70) | 0.35 (0.25–0.49) |
W: 0.20 (0.09–0.47) | 0.24 (0.16–0.36) | ||||
Carlsson10 | 4232 M+W | 60 | 11 | – | M: 0.39 (0.25–0.49) |
W: 0.44 (0.26–0.75) | |||||
Akesson11 | 24,444 W | 59 | 6 | 0.22 (0.09–0.70) | – |
Akesson14 | 20,721 M | 45–79 | 11 | 0.14 (0.04–0.43) | – |
Abbreviations: CHD, coronary heart disease; CI, confidence interval; CVD, cardiovascular disease; HR, hazard ratio; M, men; W, women.